Swiss pharma giant Novartis late Friday announced today that Cosentyx (secukinumab) received US Food and Drug Administration ...

Swiss biotech Idorsia (SIX: IDIA) said chief executive Srishti Gupta has stepped down from her role and from the company’s ...

A Japan-based biotechnology company developing small-molecule therapeutics targeting protein–protein interactions (PPIs).

Under the Medicare Drug Price Negotiation Program (Negotiation Program), the US Centers for Medicare & Medicaid Services (CMS) directly negotiates the prices of certain high expenditure, single source ...

Europe is achieving better cancer outcomes without cancer overwhelming health budgets, according to the Comparator Report on Cancer in Europe 2025 by the Swedish Institute for Health Economics (IHE).

Global drug regulators have continued to move a steady stream of approvals and recommendations through early March, with activity spanning oncology, vaccines, and regulatory policy discussions. The US ...

AstraZeneca’s Imfinzi (durvalumab) in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and docetaxel) has been approved in the European Union (EU) for the ...

French pharma major Sanofi (Euronext: SAN) will supply 600,000 doses of its protein-based COVID-19 vaccine Nuvaxovid ...

Important research news last week included Vertex announcing positive Phase III results for its povetacicept in ...

Boehringer Ingelheim announced that Hernexeos (zongertinib tablets) has been recommended as an initial treatment option for adult patients with HER2 (ERBB2)-mutant advanced non-small cell lung cancer ...

The Prescription Medicines Code of Practice Authority (PMCPA)—which operates the Code of Practice of the Association of the ...

Chinese radiopharmaceutical startup Eli Radiopharma has secured around 100 million yuan ($14.5 million) in fresh financing as ...